Prelude Therapeutics (PRLD)
NASDAQ:PRLD

Prelude Therapeutics Insider Trading Activity

Trend: â–˛ Corporate Insiders Bought Shares Worth $94.9K in the Last 3 Months.

PRLD Insider Transactions

The data in the graph is based on publicly available reports of insider transactions, as reported to the SEC.
See the number of buy and sell transactions by insiders for this stock over the past year.

Insider Confidence Signal

Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on 1 informative insider transaction by 1 unique insider from last 3 months.
The sentiment expressed in the Insider Confidence Signal is based on insider transactions over the past 3 months.

Insider Buy and Sell Transactions​

Insider Name
Role
Star Ranking
Transaction
Amount
Date
Follow
SEC
Upgrade Banner
EVP, Chief of Clinical Affairs
Not Ranked
Uninformative Sell
$373763
EVP, Chief of Clinical Affairs
Not Ranked
Uninformative Sell
$456498
EVP, Chief of Clinical Affairs
Not Ranked
Uninformative Sell
$129822
EVP, Chief of Clinical Affairs
Not Ranked
Uninformative Sell
$4000
EVP, Chief of Clinical Affairs
Not Ranked
Uninformative Sell
$40040
EVP, Head of Chemistry
Informative Buy
$94880
President & CEO,Director
Not Ranked
Uninformative Buy
$96960
CFO
Uninformative Buy
$61400
CMO
Not Ranked
Uninformative Sell
$464276
CMO
Not Ranked
Uninformative Sell
$550229
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis